SICILIANO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 40.634
EU - Europa 16.366
AS - Asia 8.154
AF - Africa 789
SA - Sud America 290
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 8
Totale 66.323
Nazione #
US - Stati Uniti d'America 37.506
IT - Italia 7.361
CN - Cina 4.260
CA - Canada 3.093
SE - Svezia 2.460
SG - Singapore 1.781
DE - Germania 1.747
BG - Bulgaria 1.461
TR - Turchia 872
GB - Regno Unito 754
VN - Vietnam 583
UA - Ucraina 581
FI - Finlandia 540
CI - Costa d'Avorio 488
AT - Austria 321
RU - Federazione Russa 313
CH - Svizzera 260
BR - Brasile 239
HK - Hong Kong 236
IN - India 204
SN - Senegal 133
FR - Francia 124
NG - Nigeria 118
BE - Belgio 99
NL - Olanda 82
IL - Israele 54
NZ - Nuova Zelanda 42
PL - Polonia 42
ES - Italia 41
AU - Australia 40
CZ - Repubblica Ceca 40
BJ - Benin 26
JP - Giappone 26
MX - Messico 25
IR - Iran 23
GR - Grecia 22
IE - Irlanda 22
LT - Lituania 19
AR - Argentina 17
HU - Ungheria 17
DK - Danimarca 15
EC - Ecuador 13
KR - Corea 13
TW - Taiwan 12
BD - Bangladesh 11
IQ - Iraq 11
PH - Filippine 10
ZA - Sudafrica 9
ID - Indonesia 8
CL - Cile 7
EU - Europa 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
PE - Perù 6
RO - Romania 6
UZ - Uzbekistan 6
EE - Estonia 5
TH - Thailandia 5
EG - Egitto 4
HR - Croazia 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
CO - Colombia 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
VE - Venezuela 3
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
JM - Giamaica 2
JO - Giordania 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DM - Dominica 1
GA - Gabon 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
Totale 66.317
Città #
Woodbridge 5.588
Fairfield 3.780
Houston 3.773
Ann Arbor 3.390
Chandler 2.769
Santa Clara 2.442
Montreal 2.303
Ashburn 1.867
Seattle 1.757
Milan 1.507
Sofia 1.459
Shanghai 1.361
Wilmington 1.332
Serra 1.306
Cambridge 1.271
New York 945
Beijing 941
Singapore 928
Jacksonville 789
Ottawa 744
Boardman 715
Princeton 666
Izmir 617
Lawrence 594
Medford 551
Abidjan 488
Nanjing 430
Florence 423
Rome 342
Des Moines 325
Vienna 308
Bern 233
Istanbul 233
Pisa 231
Dong Ket 226
Hong Kong 215
San Diego 208
Frankfurt am Main 200
Dearborn 188
Nanchang 186
London 184
Ogden 172
Jüchen 151
Bremen 142
Redwood City 135
Dakar 133
Lagos 117
Kunming 103
Norwalk 98
Hebei 93
Lancaster 88
Brussels 87
Shenyang 87
Changsha 85
Fuzhou 77
Los Angeles 69
Dallas 67
Pune 67
Boulder 63
Livorno 62
Jiaxing 60
Tianjin 60
Falls Church 59
Munich 56
Washington 54
Naples 52
Chicago 51
Helsinki 49
Nürnberg 46
Vicopisano 46
Guangzhou 45
Hefei 40
Detroit 39
Warsaw 39
Genoa 37
Orange 37
Quanzhou 35
Auburn Hills 34
Hangzhou 34
Turin 33
Düsseldorf 32
Fondi 32
Lucca 32
Kent 30
Brno 28
San Francisco 28
Bergamo 27
Cascina 27
Jinan 27
Cotonou 26
Bologna 25
Lanzhou 25
Verona 25
São Paulo 24
Hyderabad 23
Lappeenranta 23
Changchun 22
Palermo 22
Phoenix 21
Trieste 21
Totale 51.137
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.364
Stima della prevalenza della sclerosi laterale amiotrofica (SLA): elaborazione di un algoritmo dai dati sanitari routinari 1.973
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 251
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 229
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 225
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 214
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 203
Metabolic myopathies: functional evaluation by different exercise testing approaches 196
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 194
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 192
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 191
Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children 186
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 185
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 183
The role of mitochondria in stem cell biology 182
Mitochondrial DNA-related disorders 180
Antimyoclonic effect of levetiracetam in MERRF syndrome 178
Dream recall in patients with focal cerebral lesions. 177
Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. 175
Mitochondria, cognitive impairment, and Alzheimer's disease. 173
A case of pelvic floor myoclonic jerk syndrome. 170
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 169
An atypical presentation of sporadic adult-onset centronuclear myopathy 168
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 167
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 166
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 165
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 164
Inflammatory myopathy in a patient with postural and kinetik tremor. 163
Dysphagia in Amyotrophic Lateral Sclerosis: relationshisp between disease progression and fiberoptic endoscopic evaluation of swallowing. 163
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 162
Clinical Trials for Neuroprotection in ALS 162
Effects of anticholinergic agents on the excitability of the blink reflex in Meige syndrome. 161
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 161
High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis 160
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 160
Progressive sensorineural hearing loss in childhood 159
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 158
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 158
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 158
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 158
Psychiatric involvement in adult patients with mitochondrial disease. 158
A STANDARDIZED CLINICAL EVALUATION OF PATIENTS AFFECTED BY FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: THE FSHD CLINICAL SCORE 157
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 157
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 157
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 157
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 156
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease 156
Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 156
Tarsal tunnel syndrome in seronegative spondyloarthropathy. 155
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 155
Mitochondrial DNA single deletion in a patient with postural tremor. 154
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 154
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier 153
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 153
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 153
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. 152
Mitochondria and neurodegeneration 152
Astrocyte-neuron interactions in neurological disorders 152
Pain threshold and polysynaptic components of the blink reflex in Parkinson's disease. 151
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 151
Variability of the expression of muscle mitochondrial damage in ocular mitochondrial myopathy. 151
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. 150
Reply to P.M. Foye ( Letter ) 150
Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: a molecular genetics-based epidemiological and genotype-phenotype study 150
Mitochondrial peripheral benzodiazepine receptor in amyotrophic lateral sclerosis 149
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 149
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 149
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? 148
Impaired oxidative metabolism in exercising muscle from ALS patients. 148
The hOGG1 Ser326Cys polymorphism and Huntington's disease 148
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 148
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 147
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 146
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 146
The Role of Mitochondria in StemCell Biology 146
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 146
Drugs and mitochondrial diseases: 40 queries and answers. 145
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 145
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 145
Tetracycline treatment in patients with progressive external ophthalmoplegia. 144
Effects of grating spatial orientation on visual evoked potentials and contrast sensitivity in multiple sclerosis 144
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients 144
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 143
Mitochondrial dysfunction and Alzheimer's disease: new developments 142
Oxidative stress modulation in neurodegenerative diseases 142
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 142
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 142
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 141
Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy 141
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 141
The role of mitochondria in stem cell biology 141
A new truncating MPZ mutation associated with a very mild CMT1 B phenotype 140
Thyroid function and oral TRH in amyotrophic lateral sclerosis 139
COX AND MITOCHONDRIAL F1F0-ATPASE (ATP SYNTHASE) ACTIVITIES IN PLATELETS AND BRAIN FROM PATIENTS WITH ALZHEIMER'S DISEASE 139
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 139
Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency. 139
Abnormal H-Tfam in a patient harboring a single mtDNA deletion. 139
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 139
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 139
New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. 138
Totale 19.956
Categoria #
all - tutte 183.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.952 0 0 0 0 0 0 1.183 811 1.173 723 871 191
2020/20214.646 406 275 293 255 452 272 337 435 439 399 331 752
2021/20226.582 134 390 182 434 1.180 842 183 403 308 218 486 1.822
2022/20239.154 953 1.138 600 813 1.025 1.068 117 672 1.661 106 808 193
2023/20249.950 844 781 880 512 1.050 1.252 401 265 178 2.577 445 765
2024/20257.604 195 818 324 1.261 1.987 2.074 945 0 0 0 0 0
Totale 67.313